How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
37
INMD Quote, Financials, Valuation and Earnings
Last price:
$15.91
Seasonality move
:
-10.94%
Day range:
$14.96 - $15.25
52-week range:
$13.14 - $19.78
Dividend yield:
0%
P/E ratio:
6.99x
P/S ratio:
2.80x
P/B ratio:
1.46x
Volume:
735.9K
Avg. volume:
757.7K
1-year change:
-12.2%
Market cap:
$955.7M
Revenue:
$394.8M
EPS (TTM):
$2.16
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
INMD
InMode Ltd.
|
$101.7M | $0.42 | 5.26% | 31.32% | $16.60 |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -57.02% | -40.33% | $12.3077 |
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | 8.36% | 39.86% | $14.20 |
|
VNRX
VolitionRX Ltd.
|
$714.1K | -$0.04 | 227.21% | -28.83% | $2.20 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
INMD
InMode Ltd.
|
$15.12 | $16.60 | $955.7M | 6.99x | $0.00 | 0% | 2.80x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.5600 | $12.3077 | $190.3M | -- | $0.00 | 0% | 173.58x |
|
INFU
InfuSystem Holdings, Inc.
|
$8.11 | $14.20 | $164.9M | 31.01x | $0.00 | 0% | 1.22x |
|
VNRX
VolitionRX Ltd.
|
$0.26 | $2.20 | $31.9M | -- | $0.00 | 0% | 17.82x |
|
VTAK
Catheter Precision, Inc.
|
$2.09 | -- | $2.6M | 0.40x | $0.00 | 0% | 9.83x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.64 | $1.50 | $88.9M | 62.25x | $0.00 | 0% | 0.69x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
INMD
InMode Ltd.
|
0.85% | 0.668 | 0.59% | 8.35x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.042 | 11.73% | 1.35x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.723 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | 0.156 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 3.120 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
INMD
InMode Ltd.
|
$72.3M | $20.9M | 22.18% | 22.38% | 22.43% | $27M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
InMode Ltd. vs. Competitors
-
Which has Higher Returns INMD or CATX?
Perspective Therapeutics, Inc. has a net margin of 23.47% compared to InMode Ltd.'s net margin of -12425.36%. InMode Ltd.'s return on equity of 22.38% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About INMD or CATX?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 9.79%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 380.77%. Given that Perspective Therapeutics, Inc. has higher upside potential than InMode Ltd., analysts believe Perspective Therapeutics, Inc. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 5 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is INMD or CATX More Risky?
InMode Ltd. has a beta of 2.129, which suggesting that the stock is 112.861% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock INMD or CATX?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or CATX?
InMode Ltd. quarterly revenues are $93.2M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. InMode Ltd.'s net income of $21.9M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.99x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.80x versus 173.58x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.80x 6.99x $93.2M $21.9M CATXPerspective Therapeutics, Inc.173.58x -- $209K -$26M
-
Which has Higher Returns INMD or INFU?
InfuSystem Holdings, Inc. has a net margin of 23.47% compared to InMode Ltd.'s net margin of 6.19%. InMode Ltd.'s return on equity of 22.38% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M -
What do Analysts Say About INMD or INFU?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 9.79%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 75.09%. Given that InfuSystem Holdings, Inc. has higher upside potential than InMode Ltd., analysts believe InfuSystem Holdings, Inc. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 5 0 INFUInfuSystem Holdings, Inc.5 0 0 -
Is INMD or INFU More Risky?
InMode Ltd. has a beta of 2.129, which suggesting that the stock is 112.861% more volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.
-
Which is a Better Dividend Stock INMD or INFU?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or INFU?
InMode Ltd. quarterly revenues are $93.2M, which are larger than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. InMode Ltd.'s net income of $21.9M is higher than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.99x while InfuSystem Holdings, Inc.'s PE ratio is 31.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.80x versus 1.22x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.80x 6.99x $93.2M $21.9M INFUInfuSystem Holdings, Inc.1.22x 31.01x $36.5M $2.3M
-
Which has Higher Returns INMD or VNRX?
VolitionRX Ltd. has a net margin of 23.47% compared to InMode Ltd.'s net margin of -862.39%. InMode Ltd.'s return on equity of 22.38% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About INMD or VNRX?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 9.79%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 746.15%. Given that VolitionRX Ltd. has higher upside potential than InMode Ltd., analysts believe VolitionRX Ltd. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 5 0 VNRXVolitionRX Ltd.4 2 0 -
Is INMD or VNRX More Risky?
InMode Ltd. has a beta of 2.129, which suggesting that the stock is 112.861% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.
-
Which is a Better Dividend Stock INMD or VNRX?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or VNRX?
InMode Ltd. quarterly revenues are $93.2M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. InMode Ltd.'s net income of $21.9M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.99x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.80x versus 17.82x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.80x 6.99x $93.2M $21.9M VNRXVolitionRX Ltd.17.82x -- $627.3K -$5.4M
-
Which has Higher Returns INMD or VTAK?
Catheter Precision, Inc. has a net margin of 23.47% compared to InMode Ltd.'s net margin of -1037.17%. InMode Ltd.'s return on equity of 22.38% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About INMD or VTAK?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 9.79%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1718.24%. Given that Catheter Precision, Inc. has higher upside potential than InMode Ltd., analysts believe Catheter Precision, Inc. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 5 0 VTAKCatheter Precision, Inc.0 0 0 -
Is INMD or VTAK More Risky?
InMode Ltd. has a beta of 2.129, which suggesting that the stock is 112.861% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.392, suggesting its less volatile than the S&P 500 by 239.195%.
-
Which is a Better Dividend Stock INMD or VTAK?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or VTAK?
InMode Ltd. quarterly revenues are $93.2M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. InMode Ltd.'s net income of $21.9M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.99x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.80x versus 9.83x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.80x 6.99x $93.2M $21.9M VTAKCatheter Precision, Inc.9.83x 0.40x $226K -$2.3M
-
Which has Higher Returns INMD or XTNT?
Xtant Medical Holdings, Inc. has a net margin of 23.47% compared to InMode Ltd.'s net margin of 3.93%. InMode Ltd.'s return on equity of 22.38% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital INMDInMode Ltd.77.61% $0.34 $659M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About INMD or XTNT?
InMode Ltd. has a consensus price target of $16.60, signalling upside risk potential of 9.79%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 136.22%. Given that Xtant Medical Holdings, Inc. has higher upside potential than InMode Ltd., analysts believe Xtant Medical Holdings, Inc. is more attractive than InMode Ltd..
Company Buy Ratings Hold Ratings Sell Ratings INMDInMode Ltd.0 5 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is INMD or XTNT More Risky?
InMode Ltd. has a beta of 2.129, which suggesting that the stock is 112.861% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.
-
Which is a Better Dividend Stock INMD or XTNT?
InMode Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. InMode Ltd. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios INMD or XTNT?
InMode Ltd. quarterly revenues are $93.2M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. InMode Ltd.'s net income of $21.9M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, InMode Ltd.'s price-to-earnings ratio is 6.99x while Xtant Medical Holdings, Inc.'s PE ratio is 62.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for InMode Ltd. is 2.80x versus 0.69x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income INMDInMode Ltd.2.80x 6.99x $93.2M $21.9M XTNTXtant Medical Holdings, Inc.0.69x 62.25x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 65x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
82
STX alert for Jan 29
Seagate Technology Holdings Plc [STX] is down 0.33% over the past day.
Buy
71
CLS alert for Jan 29
Celestica, Inc. [CLS] is down 16.87% over the past day.
Buy
58
AAOI alert for Jan 29
Applied Optoelectronics, Inc. [AAOI] is down 14.44% over the past day.
